| Nome |
# |
|
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?, file e2913fd9-efc1-f688-e053-3705fe0a67e0
|
313
|
|
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome, file e2913fda-c031-f688-e053-3705fe0a67e0
|
293
|
|
Pharmacogenetics of thiopurines, file e2913fdc-94d6-f688-e053-3705fe0a67e0
|
267
|
|
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease, file e2913fdf-5396-f688-e053-3705fe0a67e0
|
208
|
|
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients, file e2913fdc-38a0-f688-e053-3705fe0a67e0
|
201
|
|
Pharmacogenetics of treatments for inflammatory bowel disease, file e2913fdf-50a2-f688-e053-3705fe0a67e0
|
198
|
|
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles, file e2913fdc-5c32-f688-e053-3705fe0a67e0
|
195
|
|
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events, file e2913fdd-4032-f688-e053-3705fe0a67e0
|
171
|
|
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay, file e2913fdb-91a9-f688-e053-3705fe0a67e0
|
160
|
|
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia, file e2913fdc-9ee2-f688-e053-3705fe0a67e0
|
158
|
|
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease, file e2913fdc-e8d6-f688-e053-3705fe0a67e0
|
156
|
|
Genetic determinants for methotrexate response in juvenile idiopathic arthritis, file e2913fd9-70fa-f688-e053-3705fe0a67e0
|
152
|
|
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children, file e2913fd9-a11e-f688-e053-3705fe0a67e0
|
152
|
|
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians, file e2913fdf-5a0c-f688-e053-3705fe0a67e0
|
152
|
|
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants, file e2913fdc-9ee7-f688-e053-3705fe0a67e0
|
150
|
|
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance, file e2913fda-82e3-f688-e053-3705fe0a67e0
|
147
|
|
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis, file e2913fd9-7a99-f688-e053-3705fe0a67e0
|
145
|
|
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms, file e2913fd9-5e4a-f688-e053-3705fe0a67e0
|
128
|
|
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease, file e2913fdd-784a-f688-e053-3705fe0a67e0
|
120
|
|
Pharmacogenomics of antibiotics, file e2913fdd-ad8a-f688-e053-3705fe0a67e0
|
104
|
|
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies, file e2913fdf-235b-f688-e053-3705fe0a67e0
|
94
|
|
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease, file e2913fd9-6ed7-f688-e053-3705fe0a67e0
|
88
|
|
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol, file e2913fdf-199a-f688-e053-3705fe0a67e0
|
86
|
|
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis, file e2913fda-838a-f688-e053-3705fe0a67e0
|
84
|
|
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers, file e2913fde-8807-f688-e053-3705fe0a67e0
|
84
|
|
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response, file e2913fd9-7b4f-f688-e053-3705fe0a67e0
|
81
|
|
SERS of cells: What can we learn from cell lysates?, file e2913fdf-0651-f688-e053-3705fe0a67e0
|
80
|
|
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells, file e2913fdf-9bb9-f688-e053-3705fe0a67e0
|
77
|
|
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention, file e2913fde-da00-f688-e053-3705fe0a67e0
|
76
|
|
Role of inosine triphosphate pyrophosphatase gene variant on fever incidence during zidovudine antiretroviral therapy, file e2913fdd-8a68-f688-e053-3705fe0a67e0
|
75
|
|
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome, file e2913fda-a232-f688-e053-3705fe0a67e0
|
69
|
|
Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide, file e2913fdf-4d60-f688-e053-3705fe0a67e0
|
66
|
|
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects, file e2913fd9-9fee-f688-e053-3705fe0a67e0
|
65
|
|
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients, file e2913fdf-3138-f688-e053-3705fe0a67e0
|
65
|
|
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs, file 1594398c-8708-47df-9543-6c4c134afa07
|
64
|
|
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease, file e2913fde-cc2b-f688-e053-3705fe0a67e0
|
60
|
|
Effect of thalidomide on clinical remission in children and adolescents with ulcerative colitis refractory to other immunosuppressives: Pilot randomized clinical trial, file e2913fdf-501d-f688-e053-3705fe0a67e0
|
48
|
|
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway, file e2913fdd-ad88-f688-e053-3705fe0a67e0
|
45
|
|
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients, file e2913fdd-70c2-f688-e053-3705fe0a67e0
|
43
|
|
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease, file 3844bc76-eee8-4b84-a647-ccd1f3bf519d
|
42
|
|
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease, file e2913fde-b6f3-f688-e053-3705fe0a67e0
|
38
|
|
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease, file c6a99495-ea4d-487c-88ba-7d779a167f9f
|
37
|
|
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD, file e2913fdd-0e50-f688-e053-3705fe0a67e0
|
36
|
|
Patient-derived organoids for therapy personalization in inflammatory bowel diseases, file 42c7286d-1ed8-4321-b309-c88fe406c27a
|
34
|
|
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway, file e2913fdd-9822-f688-e053-3705fe0a67e0
|
34
|
|
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease, file e2913fdd-11a4-f688-e053-3705fe0a67e0
|
32
|
|
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD, file e2913fdd-1e15-f688-e053-3705fe0a67e0
|
32
|
|
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias, file e2913fde-eb83-f688-e053-3705fe0a67e0
|
31
|
|
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study, file e2913fdf-9c5e-f688-e053-3705fe0a67e0
|
27
|
|
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells, file 2e82488e-c700-478b-af42-150283fa6632
|
25
|
|
Microbiota and drug response in inflammatory bowel disease, file e2913fde-581a-f688-e053-3705fe0a67e0
|
25
|
|
Bactericidal activity of three different antiseptic ophthalmic preparations as surgical prophylaxis, file e2913fdf-74ec-f688-e053-3705fe0a67e0
|
24
|
|
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know, file e2913fde-caf5-f688-e053-3705fe0a67e0
|
23
|
|
Biomarkers for gastrointestinal adverse events related to thiopurine therapy, file e2913fde-db9c-f688-e053-3705fe0a67e0
|
22
|
|
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response, file e2913fdf-9f50-f688-e053-3705fe0a67e0
|
22
|
|
A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis, file 96ac297b-fc9c-4350-83d7-341e44b7d32a
|
15
|
|
Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis, file e2913fde-eb81-f688-e053-3705fe0a67e0
|
15
|
|
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease, file e2913fde-b6f1-f688-e053-3705fe0a67e0
|
14
|
|
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells, file 1823a521-90f3-426e-a485-b4410e18f9f3
|
12
|
|
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response, file e2913fd9-2b24-f688-e053-3705fe0a67e0
|
12
|
|
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease, file e2913fde-d5b4-f688-e053-3705fe0a67e0
|
12
|
|
In vitro effects of sulforaphane on interferon-driven inflammation and exploratory evaluation in two healthy volunteers, file e2913fde-ae77-f688-e053-3705fe0a67e0
|
11
|
|
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response, file e2913fdf-6aec-f688-e053-3705fe0a67e0
|
11
|
|
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside, file 72024c06-f5bb-488e-9044-c6220f805314
|
10
|
|
Effect of thalidomide on clinical remission in children and adolescents with ulcerative colitis refractory to other immunosuppressives: Pilot randomized clinical trial, file e2913fda-4812-f688-e053-3705fe0a67e0
|
10
|
|
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study, file e2913fdc-8a25-f688-e053-3705fe0a67e0
|
10
|
|
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease, file e2913fdc-a772-f688-e053-3705fe0a67e0
|
10
|
|
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients, file e2913fde-8ebc-f688-e053-3705fe0a67e0
|
10
|
|
Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review, file 98145ca8-151a-4f9f-a7bd-c3b91d1461ae
|
9
|
|
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol, file e2913fdb-84b4-f688-e053-3705fe0a67e0
|
8
|
|
SERS of cells: What can we learn from cell lysates?, file e2913fdb-d9ba-f688-e053-3705fe0a67e0
|
8
|
|
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients, file e2913fdd-6ecf-f688-e053-3705fe0a67e0
|
8
|
|
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease, file 28c715ea-8bcf-482a-ab4b-a1aafd2dd2b6
|
7
|
|
Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide, file e2913fdb-957e-f688-e053-3705fe0a67e0
|
7
|
|
Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy, file 3f36c708-fb54-42c6-8f0f-4b9e7c168c5d
|
6
|
|
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis, file e2913fda-86eb-f688-e053-3705fe0a67e0
|
6
|
|
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia, file e2913fdd-b388-f688-e053-3705fe0a67e0
|
6
|
|
Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress, file e2913fda-9519-f688-e053-3705fe0a67e0
|
5
|
|
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine, file e2913fda-b616-f688-e053-3705fe0a67e0
|
5
|
|
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome, file e2913fda-bb54-f688-e053-3705fe0a67e0
|
5
|
|
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives, file e2913fdb-754e-f688-e053-3705fe0a67e0
|
5
|
|
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease, file e2913fdb-c79f-f688-e053-3705fe0a67e0
|
5
|
|
Pharmacogenetics of treatments for inflammatory bowel disease, file e2913fde-6ae3-f688-e053-3705fe0a67e0
|
5
|
|
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study, file 023bda0d-c8a5-474f-ac0e-050373bb39af
|
4
|
|
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs, file 22093a18-79a6-4f81-b78c-d78d531f0f1f
|
4
|
|
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis, file e2913fd9-71c1-f688-e053-3705fe0a67e0
|
4
|
|
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease., file e2913fda-41d9-f688-e053-3705fe0a67e0
|
4
|
|
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance, file e2913fda-8124-f688-e053-3705fe0a67e0
|
4
|
|
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease, file e2913fdb-54ed-f688-e053-3705fe0a67e0
|
4
|
|
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies, file e2913fdf-0ae2-f688-e053-3705fe0a67e0
|
4
|
|
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs, file 9e832f1e-f701-40b0-ad44-07bda0dcc947
|
3
|
|
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity., file e2913fd9-1333-f688-e053-3705fe0a67e0
|
3
|
|
Personalized therapies in pediatric inflammatory and autoimmune diseases., file e2913fd9-18a9-f688-e053-3705fe0a67e0
|
3
|
|
Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes, file e2913fda-81ef-f688-e053-3705fe0a67e0
|
3
|
|
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?, file e2913fda-b9c5-f688-e053-3705fe0a67e0
|
3
|
|
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5, file e2913fda-cf52-f688-e053-3705fe0a67e0
|
3
|
|
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome, file e2913fdd-1e1a-f688-e053-3705fe0a67e0
|
3
|
|
Induced pluripotent stem cells to model adverse drug reactions in pediatric patients, file e2913fde-0fa7-f688-e053-3705fe0a67e0
|
3
|
|
Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy. Function of bilitranslocase, file e2913fd8-f9db-f688-e053-3705fe0a67e0
|
2
|
|
null, file e2913fd9-0857-f688-e053-3705fe0a67e0
|
2
|
| Totale |
5.707 |